|
|
Post by u1682002 on Oct 6, 2015 18:35:32 GMT -5
If I have to pick one thing that I can hear from Matt during this Thursday conference call, I would like to hear he tells us that MNKD will no longer increase a single new share for the next two years. Any new stock options for employee will be through open-market buy-back. The returned shares from BOA will be locked. The AMT shares will only be used with a fixed floor price.
|
|
|
|
Post by xoxoxoxo on Oct 6, 2015 18:49:31 GMT -5
If I have to pick one thing that I can hear from Matt during this Thursday conference call, I would like to hear he tells us that MNKD will no longer increase a single new share for the next two years. Any new stock options for employee will be through open-market buy-back. The returned shares from BOA will be locked. The AMT shares will only be used with a fixed floor price. Perhaps you haven't been invested with the company very long, but I can guarantee beyond a shadow of a doubt that he will not use words like that. Matt already said at the last event that dilution is possible, he wanted to keep it in the ballpark of the 9m shares being returned to keep things relatively neutral, but a few million extra wouldn't be a surprise at all. |
|
|
|
Post by u1682002 on Oct 6, 2015 19:23:38 GMT -5
Xo, I am a MNKD investor since 2009 and I knew it is a wishful thinking to ask Matt to say what I want to hear. However, I feel strongly that Matt actual reads messages from this board. He may pick up a few ideas how to deliver right messages to the investing communities.
|
|
|
|
Post by falconquest on Oct 6, 2015 20:45:03 GMT -5
I have to agree with xoxoxo. you may want that from Matt, but you ain't gonna get it. I think a lot of us that have been here many years could give the presentation.
|
|
|
|
Post by dreamboatcruise on Oct 6, 2015 21:08:37 GMT -5
If we're indulging flights of fancy... I'd go further and want to hear the details of how the company will be funded for the next 12 months, which is probably a minimum before Afrezza is generating profit or hitting the first Afrezza revenue milestone payment. Simply stating there will be no further dilution isn't going to carry a lot of weight without a game plan consistent with the promise. Hopefully they'll see the remaining non-revenue milestones within that period, but the timing might get a bit tight. This level of visibility would be great, but I'd sooner bet on the NSA having an open house day.
|
|
|
|
Post by monetpenet on Oct 6, 2015 21:18:28 GMT -5
If we're indulging flights of fancy... I'd go further and want to hear the details of how the company will be funded for the next 12 months, which is probably a minimum before Afrezza is generating profit or hitting the first Afrezza revenue milestone payment. Simply stating there will be no further dilution isn't going to carry a lot of weight without a game plan consistent with the promise. Hopefully they'll see the remaining non-revenue milestones within that period, but the timing might get a bit tight. This level of visibility would be great, but I'd sooner bet on the NSA having an open house day. Hahahahahahaha... sure thing! |
|
|
|
Post by mnholdem on Oct 7, 2015 7:31:56 GMT -5
It's my understanding that the 9 million shares borrowed by Bank of America are already counted among the outstanding shares so management should simply hold them until MNKD share price is higher and then sell them only if cash is needed.
Unless I'm mistaken, those 9 million shares cannot cause further stock dilution.
|
|
|
|
Post by chicagpete on Oct 7, 2015 7:39:02 GMT -5
It's my understanding that the 9 million shares borrowed by Bank of America are already counted among the outstanding shares so management should simply hold them until MNKD share price is higher and then sell them only if cash is needed.
Unless I'm mistaken, those 9 million shares cannot cause further stock dilution.
Yep - that's how I read it. Of course this bit of information ($27M from these 9M shares) - as well as other potential increases in cash to Balance Sheet - were missing in AF's article on Monday. If Matt can just get a $1.00 increase in pps via this conference tomorrow or in next week - that would be an additional $9M in cash. We shall know more in about 24 hours............. |
|
|
|
Post by trenddiver on Oct 7, 2015 8:37:40 GMT -5
Just kinda taking a poll. Will the share price be higher or lower after Matt's presentation? I say - lower -10% lower.  |
|
|
|
Post by irrationalexubera on Oct 7, 2015 9:57:55 GMT -5
Just kinda taking a poll. Will the share price be higher or lower after Matt's presentation? I say - lower -10% lower. for a company that gets no love from wall street, you're probably right Trend. 'Progress' with TS pipeline apps will be spun negative (more cash burn until getting to market and where o where will that ever come from?), note resolution will be spun negatively regardless of how they sewed it up (AF already did this by saying dilution would have been unnoticeable and preferred to use of precious cash), news of Afrezza sales won't even be mentioned b/c of upcoming CC in a month. IMO, only announcing a SNY buy-in stake can possibly move the needle at the moment. yes, it's gloomy, but short term is ugly while the street maintains the drug is floundering (it isn't.) long term this drug takes over a majority of the market like a virus and we all win big. that's why i keep adding at these levels. |
|
|
|
Post by harrys on Oct 7, 2015 11:43:48 GMT -5
Just kinda taking a poll. Will the share price be higher or lower after Matt's presentation? I say - lower -10% lower. We'll need a bombshell of a presentation, anything less and the shorts will use this event to finally push us below $3 as they have done with bad-neutral publicity in the past. One of their favorite methods out of the short playbook involves setting up little self fulfilling prophecies. |
|
|
|
Post by mssciguy on Oct 7, 2015 12:06:46 GMT -5
Just kinda taking a poll. Will the share price be higher or lower after Matt's presentation? I say - lower -10% lower. We'll need a bombshell of a presentation, anything less and the shorts will use this event to finally push us below $3 as they have done with bad-neutral publicity in the past. One of their favorite methods out of the short playbook involves setting up little self fulfilling prophecies. The Motley Stool /TST articles have increasingly immature titles. Are they mocking themselves? Real nRx, refill growth, prescribing physician and insurance coverage growth, check, check, check, check.... |
|
|
|
Post by od on Oct 7, 2015 12:22:07 GMT -5
We'll need a bombshell of a presentation, anything less and the shorts will use this event to finally push us below $3 as they have done with bad-neutral publicity in the past. One of their favorite methods out of the short playbook involves setting up little self fulfilling prophecies. The Motley Stool /TST articles have increasingly immature titles. Are they mocking themselves? Real nRx, refill growth, prescribing physician and insurance coverage growth, check, check, check, check.... I am with you, except - I am concerned that NRx activity is the core provider base writing additional prescriptions (good) rather then a broadening of the base of prescribing providers. |
|
|
|
Post by harrys on Oct 7, 2015 12:50:05 GMT -5
We'll need a bombshell of a presentation, anything less and the shorts will use this event to finally push us below $3 as they have done with bad-neutral publicity in the past. One of their favorite methods out of the short playbook involves setting up little self fulfilling prophecies. The Motley Stool /TST articles have increasingly immature titles. Are they mocking themselves? Real nRx, refill growth, prescribing physician and insurance coverage growth, check, check, check, check.... "Another month, another crushing decline for Mannkind"... the reality is MNKD is a windfall of clicks* for Motley Fool. Im not even sure they are implicated in the manipulation, they just write what gets them clicks and MNKD is one of the most controversial stocks out there right now. Its kindof funny when you realize they only ever report what HAS happened already as if they are breaking news and the first on scene predicting a trend. People read this shit, misery loves company... the logic contained in many of these "articles" is "the price is down because MNKD is in decline, MNKD is in decline because the price is down", its just roundabout nonsense with no insight to be found. |
|
|
|
Post by karl on Oct 7, 2015 12:56:49 GMT -5
Doesn't look like there is broadening of the provider base. The NRx has become flat. This makes me believe that there are no Rep on the field, or if there are then they are just wiling away the time.
|
|
